IntegraGen SA (ALINT)-Product Pipeline Analysis, 2016 Update

IntegraGen SA (ALINT)-Product Pipeline Analysis, 2016 Update

  • Products Id :- GDME45731PD
  • |
  • Pages: 27
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

IntegraGen SA (IntegraGen) is a biotechnology company that offers clinical genomic services to academic researchers and life sciences companies. The company provides advanced bioinformatics and biostatistical analytical tools and services. Its genomic services include clinical research, basic and human genetic research, bioinformatics and bioanalysis, agrigenomics and microbial genomics. IntegraGen also offers DNA extraction, management samples, study design, strategy, selection markers, tagging, biostatistics analysis, and bioinformatics analysis of sequence data services. The company offers services in the fields of pharmacogenetics, cytogenetics, epigenetics, and agriculture. It serves patients, clinicians and researchers. The company has its presence in France and the US. IntegraGen is headquartered in Evry, France.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company IntegraGen SA

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

IntegraGen SA Company Snapshot 6

IntegraGen SA Company Overview 6

IntegraGen SA Pipeline Products and Clinical Trials Overview 6

IntegraGen SA-Pipeline Analysis Overview 8

Key Facts 8

IntegraGen SA-Major Products and Services 9

IntegraGen SA Pipeline Products by Development Stage 10

IntegraGen SA Pipeline Products Overview 12

ARISk Test-V2.2 12

ARISk Test-V2.2 Product Overview 12

Biomarker-Based Diagnostic Test-hsa-miR-31-3p-Lung Cancer 13

Biomarker-Based Diagnostic Test-hsa-miR-31-3p-Lung Cancer Product Overview 13

CLIA Test-Hepatocellular Carcinoma 14

CLIA Test-Hepatocellular Carcinoma Product Overview 14

Laboratory Developed Test-hsa-miR-31-3p-Colorectal Cancer 15

Laboratory Developed Test-hsa-miR-31-3p-Colorectal Cancer Product Overview 15

Laboratory Developed Test-hsa-miR-31-3p-Lung Cancer 16

Laboratory Developed Test-hsa-miR-31-3p-Lung Cancer Product Overview 16

IntegraGen SA-Key Competitors 17

IntegraGen SA-Key Employees 18

IntegraGen SA-Locations And Subsidiaries 19

Head Office 19

Recent Developments 20

IntegraGen SA, Recent Developments 20

Jul 07, 2016: IntegraGen reports strong revenue growth during first half of 2016 20

Jun 06, 2016: IntegraGen Presents Positive Data at 2016 ASCO Meeting on the Role of microRNA Biomarker miR-31-3p in Patients with Metastatic Colorectal Cancer Enrolled in FIRE-3 Clinical Trial 20

Jan 14, 2016: IntegraGen Reports 2015 Revenues 21

Dec 02, 2015: IntegraGen Collaborating with FIRE-3 Clinical Trial Investigators to Study hsa-miR-31-3p Metastatic Colorectal Cancer Biomarker 21

Jun 01, 2015: IntegraGen Presents Results of Two Studies during 2015 ASCO Meeting with New Positive Data on the Role of microRNA Biomarker miR-31-3p in Patients with Metastatic Colorectal Cancer 22

Feb 05, 2015: IntegraGen Announces Distribution Agreement for Autism Risk Assessment Test 23

Feb 05, 2015: IntegraGen Announces Distribution Agreement for Autism Risk Assessment Test 23

Dec 16, 2014: IntegraGen Collaborating with PICCOLO Study Investigators to Validate Hsa-miR-31-3p Metastatic Colorectal Cancer Biomarker 24

May 19, 2014: IntegraGen Presents Data on New Version of the ARISk Test during the 13th Annual Meeting for Autism Research 24

May 15, 2014: IntegraGen Announces Publication of Study with Biomarker Associated with Survival in Metastatic Colorectal Cancer Patients Treated with Drug Therapy 25

Appendix 26

Methodology 26

About GlobalData 26

Contact Us 26

Disclaimer 27

List of Figures

IntegraGen SA Pipeline Products by Equipment Type 7

IntegraGen SA Pipeline Products by Development Stage 10

List of Tables

IntegraGen SA Pipeline Products and Clinical Trials Overview 6

IntegraGen SA Pipeline Products by Equipment Type 6

IntegraGen SA Pipeline Products by Indication 7

IntegraGen SA, Key Facts 8

IntegraGen SA, Major Products and Services 9

IntegraGen SA Number of Pipeline Products by Development Stage 10

IntegraGen SA Pipeline Products Summary by Development Stage 11

ARISk Test-V2.2-Product Status 12

ARISk Test-V2.2-Product Description 12

Biomarker-Based Diagnostic Test-hsa-miR-31-3p-Lung Cancer-Product Status 13

Biomarker-Based Diagnostic Test-hsa-miR-31-3p-Lung Cancer-Product Description 13

CLIA Test-Hepatocellular Carcinoma-Product Status 14

CLIA Test-Hepatocellular Carcinoma-Product Description 14

Laboratory Developed Test-hsa-miR-31-3p-Colorectal Cancer-Product Status 15

Laboratory Developed Test-hsa-miR-31-3p-Colorectal Cancer-Product Description 15

Laboratory Developed Test-hsa-miR-31-3p-Lung Cancer-Product Status 16

Laboratory Developed Test-hsa-miR-31-3p-Lung Cancer-Product Description 16

IntegraGen SA, Key Employees 18

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

IntegraGen SA, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license

Single User License
USD 750 INR 50588
Site License
USD 1,500 INR 67
Corporate User License
USD 2,250 INR 135



An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]